This HTML5 document contains 120 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q61862174
rdf:type
wikibase:Item
schema:description
clinical trial ensayo clínico essai clinique clinical trial clinical trial կլինիկական փորձարկում ensaio clínico klinisch onderzoek assaig clínic ensayu clínicu clinical trial клінічне випробування
rdfs:label
An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Subjects With Acute Myeloid Leukemia (AML)
skos:prefLabel
An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Subjects With Acute Myeloid Leukemia (AML)
schema:name
An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Subjects With Acute Myeloid Leukemia (AML)
p:P1476
wds:Q61862174-76ACCE39-65C9-4E60-9533-76E09580CA98
wdt:P1476
A Randomized, Multicenter, Open-label, Phase 2 Study Evaluating the Efficacy and Safety of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly (>= 65 Years) Acute Myeloid Leukemia (AML) Subjects Not Eligible for Hematopoietic Stem Cell Transplantation (HSCT)
p:P582
wds:Q61862174-5060E373-067A-4043-AD0A-76BFA03CFC6F
wdt:P582
2018-10-31T00:00:00Z
p:P31
wds:Q61862174-0B0F9D9B-56B0-45BE-81C1-6B7F21A68239
wdt:P31
wd:Q30612
p:P580
wds:Q61862174-C3AE83B8-2317-4FDA-8B58-7F2696FA7AB5
wdt:P580
2016-06-03T00:00:00Z
p:P17
wds:Q61862174-439ED659-120C-4ACE-BC4D-1002DFE41452 wds:Q61862174-31892CB3-58B5-4062-A3EF-8A82F471303E wds:Q61862174-31578778-1FC9-41C4-8C6E-E7CC6075C7DD wds:Q61862174-4EEA9089-3C65-4BEA-A3EB-2637B5859828 wds:Q61862174-4A047FE9-BC01-463F-9DBF-D5920C99C1A1 wds:Q61862174-8674954A-09A2-4817-B601-346BEF47FA8C wds:Q61862174-6E71AC1B-AD07-4B9D-93BF-A019D3BE254B wds:Q61862174-A5469C7D-E825-4E66-BE6C-4A6FBF82BBA9 wds:Q61862174-19D68208-AAA7-4D0F-B90E-1E9EED751305 wds:Q61862174-01AD6CC3-9372-4C9E-8790-9B164F91167C wds:Q61862174-C6575970-17D4-4E4F-9CFD-B8436F97443C wds:Q61862174-F90E7992-0938-4B54-8C0D-D77F981BCCBA
wdt:P17
wd:Q16 wd:Q40 wd:Q142 wd:Q31 wd:Q29 wd:Q183 wd:Q38 wd:Q30 wd:Q45 wd:Q55 wd:Q36 wd:Q145
p:P921
wds:Q61862174-42C3F0B0-E7B5-4D6C-A048-C91686EDFD64
wdt:P921
wd:Q10566551
p:P6153
wds:Q61862174-ECC088EA-A3EE-4474-9B7D-BFC7171BFBA7 wds:Q61862174-EEFD8737-BF5B-45CE-BA04-ED8AD820C5A0 wds:Q61862174-C923089F-BBF4-455D-A74D-BDB2F2FA6324 wds:Q61862174-C7F97278-6B76-4051-9035-96C4B49EA0E3 wds:Q61862174-CF1533AA-AA26-4CE2-A6EB-288A15DD792C wds:Q61862174-E5166989-F4BA-4CF9-9AC0-4E20C73497FD wds:Q61862174-E227F081-6F7D-48E3-9010-39A257CC6839 wds:Q61862174-468EEEC4-E2E2-40CD-BC3E-3E6DE1655528 wds:Q61862174-43A639C6-5D79-4324-91C0-D64F8A72759C wds:Q61862174-64C7DA33-170A-44EB-963C-610FBD50BB9F wds:Q61862174-5AE334FA-AE87-4E20-9203-8E2913A4CC9C wds:Q61862174-32A1A8B6-0219-4B05-B7F3-A4DEFCD248A9 wds:Q61862174-3B9610EA-3CCF-4960-9D46-9D1E87E4F847 wds:Q61862174-3561296A-EAEB-485B-8DF7-3E79E83A7FF9 wds:Q61862174-9D8710A8-9A14-44E6-AA67-53D58CED89C5 wds:Q61862174-9C04A9CD-65E0-4C93-9712-150A92DAE617 wds:Q61862174-A4F5FFB7-FA22-47E0-9846-D5A4214E5F72 wds:Q61862174-AD1A643C-E8BE-4D78-8B2A-969BE0DA070E wds:Q61862174-BC611249-4907-491C-BA08-4C831D3A5A38 wds:Q61862174-69E2CC25-CE1F-4D7A-BBA5-30F06051D43A wds:Q61862174-760CD717-43E0-4A89-97CB-DD1E4020C0B7 wds:Q61862174-777CE4F3-7EB4-4B35-A625-2696D7D6B540 wds:Q61862174-88BCAD62-B3DE-457B-B69E-ABD3C04E4AB2 wds:Q61862174-16A8FDD9-FF39-43A3-8A16-6799072DC45E wds:Q61862174-24A7ED8E-27FB-4204-89B7-01C3B0B97842 wds:Q61862174-2361BBA5-FE30-4D1E-BFF1-C514C64770C4
wdt:P6153
wd:Q1625100 wd:Q223429 wd:Q913126 wd:Q81949 wd:Q7914455 wd:Q2496392 wd:Q1065414 wd:Q87762406 wd:Q14875635 wd:Q3145371 wd:Q131252 wd:Q30282110 wd:Q5903125 wd:Q2945675 wd:Q5110676 wd:Q2945756 wd:Q5902584 wd:Q640694 wd:Q30279912 wd:Q501758 wd:Q245247 wd:Q2945751 wd:Q2944832 wd:Q127773 wd:Q500606 wd:Q170027
p:P4844
wds:Q61862174-81AE4472-7E07-4578-8A06-D8E878113673
wdt:P4844
wd:Q416451
p:P2899
wds:Q61862174-28BD685C-EFBF-47E0-BD5B-84D6E66A5530
wdt:P2899
18
p:P1050
wds:Q61862174-485EAE83-4F9F-4475-BFD0-13CFF60DA44B wds:Q61862174-EDC771C3-F0BE-4711-B3CF-4B99889BDA75
p:P859
wds:Q61862174-E1264B01-8E57-48E5-8F2F-23CE040E9CB0
wdt:P1050
wd:Q29496 wd:Q179630
wdt:P859
wd:Q842947
p:P1132
wds:Q61862174-B17C5AEC-FA6E-4B36-AFCD-F018C437803A
wdt:P1132
213
p:P8363
wds:Q61862174-C53024A3-6C8C-48B2-A52F-10ADC55C0904
wdt:P8363
wd:Q78089383
p:P3098
wds:Q61862174-00441AF7-E449-4129-BF50-A5723CB80701
wdt:P3098
NCT02775903
p:P6099
wds:Q61862174-F67089EC-188F-4181-ACC8-7A46935E61EC
wdt:P6099
wd:Q42824440